الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 26 |  |  |
| | | from | 26 | | |
Abstract
Since PSBD was not routinely performed in trials that confirmed the efficacy of DES, the role of PSBD following DES implantation has ultimately come into question. In clinical practice, PSBD is usually operator-decided, and is rarely performed as a standard procedure. Adjunctive PSBD with noncompliant balloons has been shown to improve both post-procedural stent dimensions and stent apposition, in turn leading to reduction of in-stent restenosis and TVR rate.
The aim of the work was to study the impact of post stent deployment balloon dilatation during primary percutaneous coronary intervention on in-hospital and long-term outcomes.
This was a prospective and retrospective study and was conducted on 307 STEMI patients collected from Alexandria Main University Hospital and International Cardiac Center (ICC). This study included 264 male patients (86%) and 43 female patients (14%). Their ages ranged from 26-85 years.
All patients were evaluated by history taking, clinical examination, routine laboratory investigations and 12-lead ECG. Coronary angiography and PCI data were recorded. Procedural and long term outcome complications were recorded in a retrospective manner from the 1st of January 2016 till end of May 2017 and prospective manner from the 1st of June 2017 till end of November 2017.
Patients were categorized into 2 groups based on PSBD procedure:
group I: Patients with STEMI who were subjected to PPCI with PSBD; 212 patients [179 males (84.4%) and 33 females (15.6%)].
group II: Patients with STEMI who were subjected to PPCI without PSBD; 95 patients [85 males (89.5%) and 10 females (10.5%)].
The results of this study revealed the following:
Coronary angiography data showed that the patients with single vessel disease were 260 (84.7%); 187 patients out of them (71.9%) were from group I, whereas 73 (28.1%) were from group II. The patients with multi vessel disease were 47 (15.3%); 25 (53.2%) patients from group I, while 22 (46.8%) were from group II. The culprit vessel was LAD (55.7%), RCA (31.6%) and LCX(12.7%) respectively.
PCI data:
Procedural comparative data included:
- Thrombus aspiration catheters: 46 patients (21.7%) from group I, and 32 patients (33.7%) of group II were managed with thrombus aspiration catheter.
- Administration of Glycoprotein IIb/IIIa inhibitors: 42 patients (19.8%) from group I were given Glycoprotein IIb/IIIa inhibitors, and 20 patients (21.1%) from group II.